| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |